Literature DB >> 20694481

Remifentanil increases the incidence of mesenteric traction syndrome: preliminary randomized controlled trial.

Yuki Nomura1, Yusuke Funai, Yohei Fujimoto, Naoto Hori, Kumiko Hirakawa, Arisa Hotta, Ai Nakamoto, Noriko Yoshikawa, Naoko Ohira, Shigeki Tatekawa.   

Abstract

PURPOSE: The use of remifentanil is often associated with the observation of mesenteric traction syndrome (MTS) soon after manipulation of the intestine during abdominal surgery. MTS symptoms include facial flushing, hypotension, and tachycardia. In the study reported here, we prospectively investigated the effects of remifentanil on the incidence of MTS in abdominal surgery.
METHODS: One hundred patients scheduled for abdominal surgery were randomly assigned to two groups. In one group (n = 50), fentanyl alone was used as intravenous analgesic (control, group C); in the second group (n = 50), both fentanyl and remifentanil were used (remifentanil group, group R). In all patients, anesthesia was induced with propofol and rocuronium and then maintained with sevoflurane inhalation. Remifentanil was continuously infused for patients in group R as an analgesic. Plasma concentration of 6-keto-PGF(1α) was measured before surgery and 20 min after the skin incision was made in six patients of group R and seven patients of group C.
RESULTS: MTS occurred in 20 cases in group R (40.0%), but in only five cases in group C (10.0%). In both groups, the incidence of MTS was higher in laparotomy than in laparoscopic surgery. The plasma concentration of 6-keto-PGF(1α) was low in both groups before surgery and was elevated 20 min after skin incision in both groups in patients in whom MTS appeared.
CONCLUSIONS: The results of this study suggest that the use of remifentanil in laparotomy facilitates MTS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694481     DOI: 10.1007/s00540-010-0998-y

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  18 in total

1.  An increase in prostacyclin accompanies reduction of blood pressure following peritoneal closure in patients undergoing cesarean section.

Authors:  M Matsumoto; H Oka; T Oshibuchi
Journal:  Anesthesiology       Date:  1989-07       Impact factor: 7.892

2.  Histamine release in mesenteric traction syndrome during abdominal aortic aneurysm surgery: prophylaxis with H1 and H2 antihistamines.

Authors:  D Duda; W Lorenz; I Celik
Journal:  Inflamm Res       Date:  2002-10       Impact factor: 4.575

3.  Changes in gastric intramucosal pH following mesenteric traction in patients undergoing pancreas surgery.

Authors:  A Brinkmann; W Seeling; M Rockemann; J H Junge; P Radermacher; H Wiedeck; M W Büchler; M Georgieff
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

4.  [The effect of indomethacin suppository in preventing mesenteric traction syndrome].

Authors:  K Koyama; I Kaneko; K Mori
Journal:  Masui       Date:  1995-08

5.  Remifentanil induces systemic arterial vasodilation in humans with a total artificial heart.

Authors:  Alexandre Ouattara; Gilles Boccara; Uwe Köckler; Patrick Lecomte; Pascal Leprince; Philippe Léger; Bruno Riou; Akthar Rama; Pierre Coriat
Journal:  Anesthesiology       Date:  2004-03       Impact factor: 7.892

6.  Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000.

Authors:  Paul Michel Mertes; Marie-Claire Laxenaire; François Alla
Journal:  Anesthesiology       Date:  2003-09       Impact factor: 7.892

7.  Remifentanil produces vasorelaxation in isolated rat thoracic aorta strips.

Authors:  H Unlügenç; M Itegin; I Ocal; M Ozalevli; T Güler; G Isik
Journal:  Acta Anaesthesiol Scand       Date:  2003-01       Impact factor: 2.105

8.  Remifentanil induces L-type Ca2+ channel inhibition in human mesenteric arterial smooth muscle cells.

Authors:  Zhao-Yang Hu; Peng-Tao Lin; Jin Liu; Da-Qing Liao
Journal:  Can J Anaesth       Date:  2008-04       Impact factor: 5.063

9.  Vasopressor hormone response following mesenteric traction during major abdominal surgery.

Authors:  A Brinkmann; W Seeling; C F Wolf; E Kneitinger; C Schönberger; N Vogt; K H Orend; M Büchler; P Radermacher; M Georgieff
Journal:  Acta Anaesthesiol Scand       Date:  1998-09       Impact factor: 2.105

10.  Comparison of surgical stress between laparoscopic and open colonic resections.

Authors:  U Hildebrandt; K Kessler; T Plusczyk; G Pistorius; B Vollmar; M D Menger
Journal:  Surg Endosc       Date:  2002-10-29       Impact factor: 4.584

View more
  10 in total

1.  Flurbiprofen axetil provides a prophylactic benefit against mesenteric traction syndrome associated with remifentanil infusion during laparotomy.

Authors:  Yohei Fujimoto; Yuki Nomura; Kumiko Hirakawa; Arisa Hotta; Ai Nakamoto; Noriko Yoshikawa; Naoko Ohira; Shigeki Tatekawa
Journal:  J Anesth       Date:  2012-03-02       Impact factor: 2.078

2.  Laser speckle contrast imaging for quantitative assessment of facial flushing during mesenteric traction syndrome in upper gastrointestinal surgery.

Authors:  Linea L Ring; Rune B Strandby; Amalie Henriksen; Rikard Ambrus; Henrik Sørensen; Jens P Gøtze; Lars B Svendsen; Michael P Achiam
Journal:  J Clin Monit Comput       Date:  2018-11-20       Impact factor: 2.502

3.  A mesenteric traction syndrome affects near-infrared spectroscopy evaluated cerebral oxygenation because skin blood flow increases.

Authors:  Niels D Olesen; Henrik Sørensen; Rikard Ambrus; Lars B Svendsen; Anton Lund; Niels H Secher
Journal:  J Clin Monit Comput       Date:  2017-03-14       Impact factor: 2.502

4.  Evaluation of the systemic inflammatory response, endothelial cell dysfunction, and postoperative morbidity in patients, receiving perioperative corticosteroid, developing severe mesenteric traction syndrome - an exploratory study.

Authors:  August Adelsten Olsen; Rune Broni Strandby; Pär Ingemar Johansson; Henrik Sørensen; Lars Bo Svendsen; Michael Patrick Achiam
Journal:  Langenbecks Arch Surg       Date:  2022-04-09       Impact factor: 2.895

5.  Development of a severe mesenteric traction syndrome during major abdominal surgery is associated with increased postoperative morbidity: Secondary data analysis on prospective cohorts.

Authors:  August A Olsen; Rune B Strandby; Nikolaj Nerup; Rikard Ambrus; Jens Peter Gøtze; Lars Bo Svendsen; Michael P Achiam
Journal:  Langenbecks Arch Surg       Date:  2019-12-09       Impact factor: 3.445

6.  Severe mesenteric traction syndrome is associated with increased systemic inflammatory response, endothelial dysfunction, and major postoperative morbidity.

Authors:  August Adelsten Olsen; Rune Broni Strandby; Nikolaj Nerup; Pär Ingemar Johansson; Lars Bo Svendsen; Michael Patrick Achiam
Journal:  Langenbecks Arch Surg       Date:  2021-03-08       Impact factor: 3.445

7.  Therapeutic effects of flurbiprofen axetil on mesenteric traction syndrome: randomized clinical trial.

Authors:  Hidemasa Takahashi; Dai Shida; Kyoko Tagawa; Ryo Iwamoto; Makoto Arita; Hiroyuki Arai; Takeo Suzuki
Journal:  BMC Surg       Date:  2017-08-11       Impact factor: 2.102

8.  Plasma pro-atrial natriuretic peptide to estimate fluid balance during open and robot-assisted esophagectomy: a prospective observational study.

Authors:  Rune Broni Strandby; Rikard Ambrus; Niels H Secher; Jens Peter Goetze; Michael Patrick Achiam; Lars Bo Svendsen
Journal:  BMC Anesthesiol       Date:  2017-02-03       Impact factor: 2.217

9.  Dexmedetomidine aggravates hypotension following mesenteric traction during total gastrectomy: a randomized controlled trial.

Authors:  Zheng Chen; Dong-Hua Shao; Xiao-Dong Ma; Zu-Min Mao
Journal:  Ann Saudi Med       Date:  2020-06-04       Impact factor: 1.526

10.  Hypotension Associated with MTS is Aggravated by Early Activation of TEA During Open Esophagectomy.

Authors:  Rune B Strandby; Rikard Ambrus; Linea L Ring; Nikolaj Nerup; Niels H Secher; Jens P Goetze; Michael P Achiam; Lars B Svendsen
Journal:  Local Reg Anesth       Date:  2021-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.